Mini Review
Published on 16 Mar 2021
Treatment of Cystic Fibrosis: From Gene- to Cell-Based Therapies
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.639475
- 26,639 views
- 27 citations
Type at least 3 characters
580 articles
Articles
Original Research
Published on 08 Mar 2021
Oral Formulation of Angiotensin-(1-7) Promotes Therapeutic Actions in a Model of Eosinophilic and Neutrophilic Asthma
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.557962
- 3,328 views
- 5 citations
Original Research
Published on 22 Feb 2021
The Influenza A Virus H3N2 Triggers the Hypersusceptibility of Airway Inflammatory Response via Activating the lncRNA TUG1/miR-145-5p/NF-κB Pathway in COPD
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.604590
- 3,844 views
- 10 citations
Original Research
Published on 22 Feb 2021
Drug Repurposing and Polypharmacology to Fight SARS-CoV-2 Through Inhibition of the Main Protease
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.636989
- 4,997 views
- 28 citations
Original Research
Published on 12 Feb 2021
Effectiveness of Benralizumab in Improving the Quality of Life of Severe Eosinophilic Asthmatic Patients: Our Real-Life Experience
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.631660
- 5,250 views
- 18 citations
Original Research
Published on 10 Feb 2021
S1PR2 Inhibition Attenuates Allergic Asthma Possibly by Regulating Autophagy
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2020.598007
- 5,161 views
- 22 citations
Original Research
Published on 05 Feb 2021
Effectiveness and Nephrotoxicity of Intravenous Polymyxin B in Chinese Patients With MDR and XDR Nosocomial Pneumonia
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2020.579069
- 3,537 views
- 12 citations
Case Report
Published on 29 Jan 2021
Case Report: Fatal Multiorgan Failure and Heterochronous Pneumonitis Following Pembrolizumab Treatment in a Patient With Large-Cell Neuroendocrine Carcinoma of Lung
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2020.569466
- 3,959 views
- 11 citations
Original Research
Published on 27 Jan 2021
Protective Effect of Arbidol Against Pulmonary Fibrosis and Sepsis in Mice
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2020.607075
- 3,933 views
- 7 citations
General Commentary
Published on 26 Jan 2021
Commentary: Paracetamol-Induced Glutathione Consumption: Is There a Link With Severe COVID-19 Illness?
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2020.625295
- 6,178 views
- 3 citations
Original Research
Published on 20 Jan 2021
Rho-Kinase 1/2 Inhibition Prevents Transforming Growth Factor-β-Induced Effects on Pulmonary Remodeling and Repair
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2020.609509
- 6,823 views
- 21 citations
Original Research
Published on 13 Jan 2021
MYH9 Inhibition Suppresses TGF-β1-Stimulated Lung Fibroblast-to-Myofibroblast Differentiation
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2020.573524
- 4,636 views
- 15 citations
Original Research
Published on 08 Jan 2021
Statins for the Treatment of Pulmonary Hypertension in Patients with Chronic Obstructive Pulmonary Disease
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2020.613761
- 3,202 views
- 4 citations
Original Research
Published on 08 Jan 2021
Alda-1 Attenuates Hyperoxia-Induced Acute Lung Injury in Mice
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2020.597942
- 5,350 views
- 21 citations
Original Research
Published on 16 Dec 2020
Arctigenin Suppressed Epithelial-Mesenchymal Transition Through Wnt3a/β-Catenin Pathway in PQ-Induced Pulmonary Fibrosis
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2020.584098
- 4,561 views
- 27 citations
Case Report
Published on 15 Dec 2020
Iacta Alea Est: The Inexorable Advance of Tofacitinib in the Treatment of Dermatomyositis-Associated Rapidly Progressive Interstitial Lung Disease. A Case Report
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2020.585761
- 7,382 views
- 8 citations